Nucleolar Sequestration of RelA (p65) Regulates NF-κB-Driven Transcription and Apoptosis

REFERENCES

• Baeuerle, P. A. 1998. Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle. Curr. Biol. 8:R19–R22.
   PubMed Web of Science ®Google Scholar
• Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167–170.
   PubMed Web of Science ®Google Scholar
• Belmont, A. 2003. Dynamics of chromatin, proteins, and bodies within the cell nucleus. Curr. Opin. Cell Biol. 15:304–310.
   PubMed Web of Science ®Google Scholar
• Birbach, A., S. T. Bailey, S. Ghosh, and J. A. Schmid. 2004. Cytosolic, nuclear and nucleolar localization signals determine subcellular distribution and activity of the NF-kappaB inducing kinase NIK. J. Cell Sci. 117:3615–3624.
   PubMed Web of Science ®Google Scholar
• Campbell, K. J., S. Rocha, and N. D. Perkins. 2004. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 13:853–865.
   PubMed Web of Science ®Google Scholar
• Carlotti, F., R. Chapman, S. K. Dower, and E. E. Qwarnstrom. 1999. Activation of nuclear factor kappaB in single living cells. Dependence of nuclear translocation and anti-apoptotic function on EGFPRELA concentration. J. Biol. Chem. 274:37941–37949.
   PubMed Web of Science ®Google Scholar
• Carmo-Fonseca, M. 2002. The contribution of nuclear compartmentalization to gene regulation. Cell 108:513–521.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., and W. C. Greene. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5:392–401.
   PubMed Web of Science ®Google Scholar
• Chen, L. F., Y. Mu, and W. C. Greene. 2002. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J. 21:6539–6548.
   PubMed Web of Science ®Google Scholar
• Datta, A., A. Nag, W. Pan, N. Hay, A. L. Gartel, O. Colamonici, Y. Mori, and P. Raychaudhuri. 2004. Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. J. Biol. Chem. 35:36698–36707.
   Google Scholar
• David-Pfeuty, T., and Y. Nouvian-Dooghe. 2002. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function. Oncogene 21:6779–6790.
   PubMedGoogle Scholar
• Dhar, S. K., B. C. Lynn, C. Daosukho, and D. K. St. Clair. 2004. Identification of nucleophosmin as an NF-κB co-activator for the induction of the human SOD2 gene. J. Biol. Chem. 279:28209–28219.
   PubMed Web of Science ®Google Scholar
• Din, F. V., M. G. Dunlop, and L. A. Stark. 2004. Evidence for colorectal cancer cell specificity of aspirin effects on NFkB signalling and apoptosis. Br. J. Cancer 91:381–388.
   PubMed Web of Science ®Google Scholar
• Fan, C., J. Yang, and J. F. Engelhardt. 2002. Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. J. Cell Sci. 115:4843–4853.
   PubMed Web of Science ®Google Scholar
• Fatyol, K., and A. A. Szalay. 2001. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia-inducible factor-1alpha (HIF-1alpha) and inhibits HIF-1-mediated transcription. J. Biol. Chem. 276:28421–28429.
   PubMed Web of Science ®Google Scholar
• Grimm, S., M. K. Bauer, P. A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis. J. Cell Biol. 134:13–23.
   PubMed Web of Science ®Google Scholar
• Hardwick, J. C., G. R. van den Brink, G. J. Offerhaus, S. J. van Deventer, and M. P. Peppelenbosch. 2001. NF-kappaB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene 20:819–827.
   PubMed Web of Science ®Google Scholar
• Harhaj, E. W., and S. C. Sun. 1999. Regulation of RelA subcellular localization by a putative nuclear export signal and p50. Mol. Cell. Biol. 19:7088–7095.
   PubMedGoogle Scholar
• Horke, S., K. Reumann, M. Schweizer, H. Will, and T. Heise. 2004. Nuclear trafficking of La protein depends on a newly identified NoLS and the ability to bind RNA. J. Biol. Chem. 279:50302–55039.
   PubMed Web of Science ®Google Scholar
• Karin, M. 1999. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 18:6867–6874.
   PubMed Web of Science ®Google Scholar
• Karin, M., Y. Cao, F. R. Greten, and Z. W. Li. 2002. NF-kappaB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2:301–310.
   PubMed Web of Science ®Google Scholar
• Kato, T., Jr., M. Delhase, A. Hoffmann, and M. Karin. 2003. CK2 is a C-terminal IkappaB kinase responsible for NF-kappaB activation during the UV response. Mol. Cell 12:829–839.
   PubMed Web of Science ®Google Scholar
• Kilbanov, S. A., H. M. O’Hagen, and M. Ljungman. 2001. Accumulation of soluble and nucleolar-associated p53 following cellular stress. J. Cell Sci. 114:1867–1873.
   PubMedGoogle Scholar
• Kopp, E., and S. Ghosh. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265:956–959.
   PubMed Web of Science ®Google Scholar
• Leung, A. K., and A. I. Lamond. 2002. In vivo analysis of NHPX reveals a novel nucleolar localization pathway involving a transient accumulation in splicing speckles. J. Cell Biol. 157:615–629.
   PubMedGoogle Scholar
• Li, N., and M. Karin. 1998. Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms. Proc. Natl. Acad. Sci. USA 95:13012–13017.
   PubMed Web of Science ®Google Scholar
• Martelli, F., T. Hamilton, D. P. Silver, N. E. Sharpless, N. Bardeesy, M. Rokas, R. A. DePinho, D. M. Livingston, and S. R. Grossman. 2001. p19ARF targets certain E2F species for degradation. Proc. Natl. Acad. Sci. USA 98:4455–4460.
   PubMed Web of Science ®Google Scholar
• Mogi, M., N. Ozeki, H. Nakamura, and A. Togari. 2004. Dual roles for NF-kappaB activation in osteoblastic cells by serum deprivation: osteoblastic apoptosis and cell-cycle arrest. Bone 35:507–516.
   PubMed Web of Science ®Google Scholar
• Niederberger, E., I. Tegeder, G. Vetter, A. Schmidtko, H. Schmidt, C. Euchenhofer, L. Brautigam, S. Grosch, and G. Geisslinger. 2001. Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J. 15:1622–1624.
   PubMed Web of Science ®Google Scholar
• Niedick, I., N. Froese, A. Oumard, P. P. Mueller, M. Nourbakhsh, H. Hauser, and M. Koster. 2004. Nucleolar localization and mobility analysis of the NF-kappaB repressing factor NRF. J. Cell Sci. 117:3447–3458.
   PubMedGoogle Scholar
• Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853–6866.
   PubMed Web of Science ®Google Scholar
• Perkins, N. D. 2004. NF-kappaB: tumor promoter or suppressor. Trends Cell Biol. 14:64–69.
   PubMed Web of Science ®Google Scholar
• Rocha, S., K. J. Campbell, and N. D. Perkins. 2003. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol. Cell 12:15–25.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M. S., J. Thompson, R. T. Hay, and C. Dargemont. 1999. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. J. Biol. Chem. 274:9108–9115.
   PubMed Web of Science ®Google Scholar
• Rodriguez, M. S., J. Wright, J. Thompson, D. Thomas, F. Baleux, J. L. Virelizier, R. T. Hay, and F. Arenzana-Seisdedos. 1996. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Oncogene 12:2425–2435.
   PubMed Web of Science ®Google Scholar
• Roff, M., J. Thompson, M. S. Rodriguez, J. M. Jacque, F. Baleux, F. Arenzana-Seisdedos, and R. T. Hay. 1996. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo. J. Biol. Chem. 271:7844–7850.
   PubMed Web of Science ®Google Scholar
• Romieu-Mourez, R., E. Landesman-Bollag, D. C. Seldin, and G. E. Sonenshein. 2002. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62:6770–6778.
   PubMed Web of Science ®Google Scholar
• Rubbi, C. P., and J. Milner. 2000. Non-activated p53 co-localizes with sites of transcription within both the nucleoplasm and the nucleolus. Oncogene 19:85–96.
   PubMed Web of Science ®Google Scholar
• Ruggero, D., and P. P. Pandolfi. 2003. Does the ribosome translate cancer. Nat. Rev. Cancer 3:179–192.
   PubMed Web of Science ®Google Scholar
• Ryan, K. M., M. K. Ernst, N. R. Rice, and K. H. Vousden. 2000. Role of NF-kappaB in p53-mediated programmed cell death. Nature 404:892–897.
   PubMed Web of Science ®Google Scholar
• Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12:1413–1426.
   PubMed Web of Science ®Google Scholar
• Smartt, H. J., D. J. Elder, D. J. Hicks, N. A. Williams, and C. Paraskeva. 2003. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells. Br. J. Cancer 89:1358–1365.
   PubMed Web of Science ®Google Scholar
• Stark, L. A., F. V. N. Din, R. M. Zwacka, and M. G. Dunlop. 2001. Aspirin-induced activation of the NF-κB signalling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J. 15:1273–1275. (First published 20 March 2001; doi:10.1096/fj.00-0529fje.)
   PubMed Web of Science ®Google Scholar
• Sweet, T., K. Khalili, B. E. Sawaya, and S. Amini. 2003. Identification of a novel protein from glial cells based on its ability to interact with NF-kappaB subunits. J. Cell. Biochem. 90:884–891.
   PubMedGoogle Scholar
• Tergaonkar, V., M. Pando, O. Vafa, G. Wahl, and I. Verma. 2002. p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy. Cancer Cell 1:493–503.
   PubMed Web of Science ®Google Scholar
• Thanos, D., and T. Maniatis. 1995. NF-kappa B: a lesson in family values. Cell 80:529–532.
   PubMed Web of Science ®Google Scholar
• Wang, C. Y., J. C. J. Cusack, R. Liu, and A. S. J. Baldwin. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat. Med. 5:412–417.
   PubMed Web of Science ®Google Scholar
• Weber, J. D., M. L. Kuo, B. Bothner, E. L. DiGiammarino, R. W. Kriwacki, M. F. Roussel, and C. J. Sherr. 2000. Cooperative signals governing ARF-Mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 20:2517–2528.
   PubMed Web of Science ®Google Scholar
• Wu, M. H., and B. Y. Yung. 2002. UV stimulation of nucleophosmin/B23 expression is an immediate-early gene response induced by damaged DNA. J. Biol. Chem. 277:48234–48240.
   PubMed Web of Science ®Google Scholar
• Yamamoto, Y., M. J. Yin, K. M. Lin, and R. B. Gaynor. 1999. Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 274:27307–27314.
   PubMed Web of Science ®Google Scholar
• Yin, M. J., Y. Yamamoto, and R. B. Gaynor. 1998. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 396:77–80.
   PubMed Web of Science ®Google Scholar
• Zwacka, R. M., L. A. Stark, and M. G. Dunlop. 2000. NF-kappaB kinetics predetermines TNF-alpha sensitivity of colorectal cancer cells. J. Gene Med. 2:334–343.
   PubMedGoogle Scholar